Taken together, these data suggest that SAA is not merely a biomarker of inflammation but that it also stimulates cells through binding various surface receptors [15] to elicit pro-inflammatory and pro-thrombotic responses that can initiate the earliest stages of vascular disease and accelerate rates of CVD and renal disorders. The gene discussed is SAA2; the disease is kidney disorder.